Article

Massive Virtual screening and evaluation of small molecule inhibitors of the Papain-like protease of SARS-CoV-2

2024-01-31

Abstract excerpt

In the face of the rapid emergence and spread of new variants of the type 2 coronavirus causing acute respiratory syndrome, it is necessary to seek new pharmacological treatments for the disease, especially for patients infected by the new and more aggressive variants of the virus. In the present work, we selected ~18,000 compounds with similar structure to GRL0617 (Tanimoto index greater than 80 %) from the PubCh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a932984b-697c-5be2-87f6-c109186040d7
DOI: 10.22541/au.170670962.27010928/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Massive Virtual screening and evaluation of small molecule inhibitors of the Papain-like protease of SARS-CoV-2DOI 10.22541/au.170670962.27010928/v1Read

Massive Virtual screening and evaluation of small molecule inhibitors of the Papain-like protease of SARS-CoV-2Semantic proximity Read

In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like ProteaseSemantic proximity Read

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach**Semantic proximity Read

Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like proteaseSemantic proximity Read

Discovery of SARS-CoV-2 papain-like protease inhibitors through machine learning and molecular simulation approachesSemantic proximity Read

Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug bindingSemantic proximity Read

Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A Medicinal Chemistry approach.Semantic proximity Read

Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Semantic proximity Read

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity Read

Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV‑2 Main ProteaseSemantic proximity Read

In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2Semantic proximity Read

High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent InhibitorSemantic proximity Read